浙江仙琚制药股份有限公司

Contribute to the cause of health

Zhejiang Xianju Pharmaceutical Co. , Ltd. (Stock Code: 002332) formerly known as Xianju Pharmaceutical Factory, was founded in 1972, is the National Torch Program Key high-tech enterprises, the company’s products Nothing in Common, adhere to the integration of raw materials, pharmaceutical business model, the main business is the development, production and sales of steroid raw materials and preparations. Xianju pharmaceutical advocates real culture, win-win culture and innovative culture, and adheres to the strategic concept of achieving win-win results in customers, enterprises, employees, society, etc. , it advocates the value idea that individual value is reflected in the process of realizing enterprise value and social value. Uphold the “Integrity, hard work, openness, learning, responsibility, win-win”core values of the enterprise, the practice of “Your health and happiness, my sincerity and service”business mission, we focus on the field of steroid with the development vision of “Becoming the top ten supplier of steroid drugs in the world, becoming the enterprise welcomed by customers and employees”.

3+2

manufacturing platforms + plants

wholly-owned and holding subsidiaries

3300

employees

980million yuan

Total capital stock

Products and Services

FDFs

The company’s featured products are cortical steroid drugs, sex hormones drugs (gynecology and family planning drugs), anaesthetic and muscle relaxant, respiratory drugs and dermatological drugs.

API & INTERMEDIATES

Bulk pharmaceutical chemicals and intermediates: steroid drugs play an important role in regulating organism and feature remarkable pharmacological action in resisting infection, allergy, virus and shock, efficacy in improving protein metabolism, recovering and enhancing health, inducing urination and lowering blood pressur, and application in the treatment of rheumatic arthritis, bronchial asthma, skin diseases like eczema, endocrine diseases including allergic shock and prostatitis as well as contraception, miscarriage prevention, menopausal symptoms relief and anesthesia.

CDMO & CMO

Custom development, registration application and safety assessment of drug substances, intermediates and impurities

R&D and Innovation

heavily investing in the innovation, research, and development of new drugs, Xianju Pharmaceutical has established an international system of synchronous R&D operation, a R&D cooperation model and a technical platform for steroid BPC and preparations that feature multiple levels and key points.

Specialized and efficient
R&D capability

Xianju has three core manufacturing platforms including Xianju Yangfu BPC Production Zone in China and two standard BPC plants in Italy, which have maximized R&D efficiency.
More
Sustainable innovation platform

Xianju has entered into long-term partnership with more than 20 domestic noted research institutes and universities including the Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences and China Pharmaceutical University, gradually globalizing its efforts in new drug research and development.
More